Top Page
China Life Insurance Co
(OTC:2628)
China Life Insurance Co (2628) vs. S&P 500 (SPY)
China Life Insurance Co Business Overview & Revenue Model
China Life Insurance Co Financial Statement Overview
| Breakdown | |||||
| TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 416.14B | 302.92B | 734.85B | 803.98B | 824.53B | 804.96B | Gross Profit |
| 416.14B | 302.92B | 829.26B | 803.98B | 824.53B | 804.96B | EBIT |
| 41.54B | 115.21B | 12.24B | 27.48B | 39.00B | 44.06B | EBITDA |
| 17.40B | 0.00 | 0.00 | 32.77B | 44.29B | 49.22B | Net Income Common Stockholders |
| 115.09B | 106.94B | 21.11B | 32.08B | 50.77B | 50.26B |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 101.84B | 86.52B | 2.41T | 1.87T | 1.49T | 1.27T | Total Assets |
| 6.98T | 6.77T | 5.89T | 5.25T | 4.89T | 4.25T | Total Debt |
| 42.85B | 49.27B | 48.97B | 49.34B | 55.86B | 57.21B | Net Debt |
| -58.99B | -37.25B | -101.55B | -78.25B | -4.58B | 583.00M | Total Liabilities |
| 6.43T | 6.25T | 5.42T | 4.81T | 4.40T | 3.80T | Stockholders Equity |
| 532.51B | 509.68B | 460.11B | 436.17B | 478.58B | 450.05B |
| Cash Flow | Free Cash Flow | ||||
| 317.19B | 374.82B | 384.06B | 348.89B | 280.97B | 296.56B | Operating Cash Flow |
| 96.79B | 378.80B | 388.23B | 351.97B | 286.45B | 304.02B | Investing Cash Flow |
| -544.86B | -354.62B | -428.10B | -164.96B | -393.73B | -292.80B | Financing Cash Flow |
| 3.85B | -86.76B | 60.27B | -120.09B | 111.14B | -7.76B |
China Life Insurance Co Technical Analysis
China Life Insurance Co Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $327.41B | 9.39 | 13.15% | 5.30% | 3.52% | 26.44% | |
75 Outperform | HK$952.23B | 3.63 | 22.83% | 4.58% | 5.96% | 124.20% | |
75 Outperform | HK$139.47B | 8.59 | 26.08% | 5.03% | -43.77% | ― | |
74 Outperform | $639.84B | 12.26 | 16.75% | 2.68% | 7.04% | 88.41% | |
72 Outperform | $928.26B | 6.69 | 5.49% | 11.71% | 37.04% | ||
70 Outperform | $295.63B | 4.63 | 16.47% | 3.93% | 11.99% | 54.60% | |
64 Neutral | $12.60B | 9.73 | 7.92% | 16985.68% | 12.21% | -5.61% |
China Life Insurance Co Earnings Call Summary
China Life Insurance Co Corporate Events
China Life Insurance Company Limited has announced the formation of a new partnership involving several entities, including CLP&C, Hebei Linkong Designated Entity, BOC-Samsung Life, and Chongqing Jiangbei Fund, with a total capital contribution of RMB5 billion. This strategic move, with China Life contributing RMB2 billion, aims to strengthen its market position and foster collaborative investment opportunities, although it is classified as a connected transaction under the Hong Kong Listing Rules, exempt from independent shareholders’ approval.
China Life Insurance Company Limited has released its solvency quarterly report for the first quarter of 2025, prepared in accordance with the regulatory standards set by the National Financial Regulatory Administration. This report highlights the company’s compliance with solvency requirements, which is crucial for maintaining its financial health and operational stability. The announcement underscores the company’s commitment to transparency and regulatory adherence, which is vital for its stakeholders and market positioning.
China Life Insurance Company Limited reported its 2025 first-quarter financial results, highlighting a 3.1% increase in total assets and a 4.5% rise in equity attributable to equity holders compared to the end of 2024. Despite an 8.9% decrease in operating income, the company achieved a significant 39.5% increase in net profit attributable to equity holders, reflecting strong financial performance and operational efficiency. The report underscores the company’s robust financial health and its strategic positioning in the insurance industry.
China Life Insurance Company Limited has announced that it will release its first quarter results for 2025 on April 29, 2025, through the Hong Kong Exchanges and Clearing Limited’s website. To provide investors with a detailed understanding of these results and the company’s operations, a results briefing will be held via webcast and text interaction on the same day. The briefing will feature the company’s President, senior management, and an Independent Non-executive Director, allowing investors to engage and ask questions. This initiative reflects the company’s commitment to transparency and investor engagement.
China Life Insurance Company Limited has announced a Board Meeting scheduled for April 29, 2025, to consider and approve the unaudited financial results for the first quarter ending March 31, 2025. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and strategic direction for the year.
China Life Insurance Company Limited has announced a final cash dividend of RMB 0.45 per share for the financial year ending December 31, 2024. The dividend will be subject to varying withholding tax rates depending on the residency and tax agreements of the shareholders, with payments scheduled for August 21, 2025. This announcement reflects the company’s stable financial performance and commitment to returning value to its shareholders.
China Life Insurance Company Limited has released its solvency quarterly report for the fourth quarter of 2024, prepared in accordance with regulatory requirements. This report reflects the company’s commitment to transparency and regulatory compliance, potentially impacting its operational strategies and stakeholder confidence.
China Life Insurance Company Limited reported strong financial results for the year ending December 31, 2024, achieving record highs in key performance indicators such as total assets, investment assets, and net profit. The company maintained its industry leadership with gross written premiums of RMB671,457 million and an embedded value surpassing RMB1.4 trillion. It also reinforced its role in supporting national development and social security, with significant investments in the real economy and advancements in environmental, social, and governance practices, earning a Grade A MSCI ESG rating.
China Life Insurance Company Limited has announced that its Board of Directors will convene on March 26, 2025, to review and approve the company’s final results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could impact the company’s financial strategy and shareholder returns.
China Life Insurance Company Limited has announced the release of its 2024 annual results, scheduled for publication on March 26, 2025, on the HKExnews website. To provide investors with a deeper understanding of its financial performance and business operations, the company will hold a webcast and text interaction briefing on March 27, 2025, featuring key executives including the Chairman and Executive Directors. This initiative aims to enhance transparency and engage stakeholders by addressing common investor queries during the session.
China Life Insurance Company Limited has announced the formation of a partnership involving several key entities, including itself, Shoujing Investment, and Chasing Jixiang as Limited Partners, alongside China Life Properties and Beijing Langjia as General Partners. The total capital contribution for the partnership is set at RMB 5,237,000,000, with China Life contributing the largest portion of RMB 3,500,000,000. This move constitutes a connected transaction under the listing rules, reflecting strategic capital alignment aimed at enhancing the company’s investment management capabilities. The partnership is structured to ensure compliance with regulatory requirements, and its establishment underscores China Life’s strategic efforts to optimize its asset management operations.